announcement, page-2

FOR IMMEDIATE RELEASE
SHAREHOLDER UPDATE
PRODUCTION OF ThermaLIFECREAM
The Company wishes to advise that it has received confirmation from Quantum
Pharmaceuticals Pty Ltd (Quantum) that production of the first batch of ThermaLIFE
Cream has been successfully completed and is currently undergoing a testing phase.
The required regulatory clearances will follow the testing phase prior to the product
being released. The Company is continuing its negotiations for distribution
arrangements and expects these to be completed shortly.
Ends
For further information:
Mr John Palermo, Chairman
Pharmanet Group Limited
Level 1, 284 Oxford Street, Leederville, Western Australia 6007
Phone: +61 8 9242 2999
Fax: +61 8 9443 2859
Email: [email protected]
About ThermaLIFECream
ThermaLIFE Cream is a product that will be sold as an OTC
(over the counter) line through the pharmacy networks. Its
indication is for the temporary relief of musculoskeletal and
arthritic pain.